ERIKA CADLE: Open Payments
NPI 1598233959 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,268 in 71 payments from 17 companies in 2025. Trend: 2023 $1,696 · 2024 $2,017 · 2025 $1,268
Food & beverage: $1,268
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $257 |
| PFIZER INC. | 16 | $140 |
| AstraZeneca Pharmaceuticals LP | 4 | $137 |
| Novo Nordisk Inc | 8 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $93 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Lilly USA, LLC | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
Products named: VRAYLAR, NURTEC ODT, Kerendia, AIRSUPRA, Ozempic, TRELEGY ELLIPTA, CAPLYTA, MOUNJARO.
Industry payments across IN — which companies pay providers there.
